Clinical trial

Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

NCT00234117

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Rabeprazole Normalized identity: rabeprazoleView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-07-01

PhaseNA

Conditions

Bronchial Asthmaunresolved

Gastroesophageal Refluxverified · MONDO: gastroesophageal reflux disease

Interventions

RabeprazoleDRUG · verified · RxNorm: rabeprazole

Sponsors & collaborators

Ponce Gastroenterology Researchlead sponsor

PriCara, Unit of Ortho-McNeil, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00234117 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.